Summary: Sex-related differences are known to exist in the haemostatic variables of adults. In the present study, three clotting factors were measured in cord blood of 191 newborns. A sex-related difference was found for clotting factor VII, with higher plasma levels in female newboms (p < 0.01). Factor VIIIic also tended to be higher in female newboms, compafed with male newborns (p = 0.07). No difference in fibrinogen concentrations was found.
Introduction
Cardiovascular disease is about twice äs frequent in men than in women (1) . Various studies have focused on hormonal Status (2-4), lipid spectrum (5) and iron storage (6) , but no conclusive explanation for this difference in incidence has been found.
Since haemostatic variables (fibrinogen, factor VlI and to a lesser extent factor VIILc) are recognized äs important iridependent risk factors for cardiovascular disease, they have been the subject of extensive research (7) (8) (9) (10) . Sex-related difference in these haemostatic variables have been shown in young adults äs well äs in the eld* erly (11) (12) (13) .
The aim of the present study was to document fibrinogen, clotting factor VH and factor VIII:c concentrations in cord blood and to determine whether sex-related differences can be demonstrated in the newbora.
Materials and Methods

Patient s
Clotting factors VII, VHI:c and fibrinogen were measured in venous cord blood from 92 male and 99 female singleton newborns Eur. J. Clin, Chem. Clin. Biochem. / Vol. 32,1994 / No. 4 born between February and August 1992, with a gestational age of 37 weeks or more, and a birth weight between the 2.3rd and 97.7th percentile for gestationai age (14) . The haematocrit values ranged from 0.45 to 0.51 l/l. Matemai exclusion criteria were a diastolic blood pressure ^ 90 mmHg, an endocrine disease, a coagulation disorder, or medication known to interfere with the haemostatic system. Gestational age was determined by the last menstrual date and/or ultrasound determinations. Birth weight was recorded.
Methods
Venous cord blood samples were collected in plastic, citrate-contäining tubes immediately after delivery and after clamping of the umbilical cord. The tubes were filled with 9 volumes of freshly drawn blood and l volume of trisodium citrate (0.11 mol/1). Citrated plasma was prepared by direct centrifugation for 20 minutes at 1800 g, snap frozen, then stored at -70 °C. It was thawed with tap water at 37 °C for 5 minutes before use.
Fibrinogen was determined with the clotting assay of Clauss, a turbidimetric method employing the CTS-fibrinogen reagent on the Chromotime System (Behring, Marburg, Germany). To quantify factor VII we used the chromogenic Substrate COA-set of Kabi Vitrum Diagnostica (Mölndal, Sweden). The intra-assay coefficient of Variation was 6.9% at the level of 54.9%. Factor VIII:c was measured with an APTT one stage clotting assay using a deficient plasma (Behring, Märburg, Germany).
Statistics
The Mann-Whitney U test was used to tcst the significance of differences between groups at the p < 0.05 level. Birth weight was significantly higher in male neonates 6 --than in female neonates. The median fibrinogen concenl trations were equal for male and female newboras, although ihe distribuiion was aussian in males and ° o ao skewed to the right in fernales.
Factor VII levels were significantly higher in female than in male newborns (median values 50% and 44%, 30 ' c respectively, both Gaussion distributed). ·£° 25 · Factor VIII:c levels tended to be higher in female than | r male neonates (median vahies 142% and 107%, respectg ively), but Ihis difference was not significant (p = 0.07).
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The distribution of the clotting factors for each sex sep- 16 . \\ -Γ arately is shown in figure la- (11) . Less research has been done on sex-related differences in factor VIII:c, but Balleisen et al. reported no difference (13) . In the present study in newborns, no difference between the sexes could be demonstrated in plasma fibrinogen concentrations. Factor VII levels in cord biood were significantly higher in female than in male neonates. Higher plasma levels of factor VIII:c in female neonates were found, but the difference did not reach the 0.05 level of significance (p = 0.07), possibly because factor VIII:c levels Span a wide ränge.
The clinical relevance of the sex-related differences in ; factor VII levels in newborns might be questioned, äs the plasma levels are lower in males than in females. It i s unlikely that this small percentage causes a difference in haemostasis between the two sexes. However, the present study provides Information about the distribution of the coagulation risk factors in the sexes at birth. It has been stated that sex-related differences in haemostatic ! i variables are related to hormonal effects.
Heller et al. found no association between testosterone and fibrinogen or factor VIII:c, but they found an inverse relationship between testosterone and factor VII in adult males (18). Since male neonates have higher testosterone values than female neonates (19), lower factor VII levels could be expected. The results of the present study are in agreement with this supposition. Moreover, oestrogen replacement therapy after onset of the menopause increases factor VII levels (12, 20) . This Supports the observation that female neonates -experiencing high oestrogen concentrations during the first week of life (19) -have higher factor VII levels. Less is known about hormonal influences on factor VIII:c. A rise in factor VHT.c levels in the postmenopausal period has been reported (13), but not confirmed by others (20).
Although hormonal characteristics may play a role, no definite explanation for the differences found can be given. It is striking, however, that plasma levels of factor VII, an important cardiovascular risk factor, appear to be higher in females than in males from birth to adult life, whereas cardiovascular disease is more frequent in men.
